加载中
NASDAQBasic MaterialsOther Precious Metals
最新数据
US$5.13
−US$0.75 · -12.76%
Greenland Mines Ltd operates across two segments: natural resources and cell and gene therapy. Its resources arm is focused on exploring for palladium, gold, and platinum, centered on the exploration and development of the Skaergaard project in Southeast Greenland. On the therapeutics side, the company is developing KLTO-202, a gene therapy targeting the treatment and prevention of amyotrophic lateral sclerosis (ALS), and KLTO-101, aimed at treating or preventing Alzheimer's disease, alongside therapies for Parkinson's and other age-related conditions. Previously known as Klotho Neurosciences, Inc., the company adopted its current name in March 2026. It is headquartered in Charlotte, North Carolina.
前收盘价
US$5.13
−US$0.75 · -12.76%
盘中时间采用ET。市场数据可能有所延迟。
Greenland Mines Ltd operates across two segments: natural resources and cell and gene therapy. Its resources arm is focused on exploring for palladium, gold, and platinum, centered on the exploration and development of the Skaergaard project in Southeast Greenland. On the therapeutics side, the company is developing KLTO-202, a gene therapy targeting the treatment and prevention of amyotrophic lateral sclerosis (ALS), and KLTO-101, aimed at treating or preventing Alzheimer's disease, alongside therapies for Parkinson's and other age-related conditions. Previously known as Klotho Neurosciences, Inc., the company adopted its current name in March 2026. It is headquartered in Charlotte, North Carolina.
日内区间
当前US$5.13
52周区间
当前US$5.13
盘中时间采用ET。市场数据可能有所延迟。
Greenland Mines Ltd operates across two segments: natural resources and cell and gene therapy. Its resources arm is focused on exploring for palladium, gold, and platinum, centered on the exploration and development of the Skaergaard project in Southeast Greenland. On the therapeutics side, the company is developing KLTO-202, a gene therapy targeting the treatment and prevention of amyotrophic lateral sclerosis (ALS), and KLTO-101, aimed at treating or preventing Alzheimer's disease, alongside therapies for Parkinson's and other age-related conditions. Previously known as Klotho Neurosciences, Inc., the company adopted its current name in March 2026. It is headquartered in Charlotte, North Carolina.
日内区间
当前US$5.13
52周区间
当前US$5.13
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 研究与开发 | 63.42万 USD | — | — | — | — |
| 销售、一般及管理费用 | 651.21万 USD | 554.02万 USD | 63.13万 USD | 53.4万 USD | 110.91万 USD |
| 营业费用 | 714.63万 USD | 554.02万 USD | 63.13万 USD | 65.7万 USD | 110.91万 USD |
| 利息收入 | — | — | — | 128.05万 USD | — |
| 利息支出 | 231.4万 USD | 35.66万 USD | 7.62万 USD | — | — |
| 折旧和摊销 | — | — | — | — | 110.91万 USD |
| 营业利润 | −714.63万 USD | −554.02万 USD | −63.13万 USD | −65.7万 USD | −110.91万 USD |
| 净利润 | −1055.17万 USD | −615.04万 USD | −70.75万 USD | 123.34万 USD | −110.9万 USD |
公司数据更新于 2026年10月11日。
近期已公布业绩
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
